Treatment of Patients with Hematologic Neoplasm, Fever, and Neutropenia
2005; Oxford University Press; Volume: 40; Issue: Supplement_4 Linguagem: Inglês
10.1086/427330
ISSN1537-6591
Autores Tópico(s)Mycobacterium research and diagnosis
ResumoChoices of empirical antibiotic therapy for patients with febrile neutropenia must be made with very little information about the source and site of infection. The clinician is aided by recognition of the subtle signs and symptoms of infection in immunocompromised patients. National guidelines should be applied according to the microbiological patterns and trends in drug resistance at each institution. Case studies are provided to illustrate these challenges in daily practice.
Referência(s)